15-43601535-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_153700.2(STRC):​c.4562G>A​(p.Arg1521Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0531 in 1,613,514 control chromosomes in the GnomAD database, including 3,329 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1521W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.041 ( 225 hom., cov: 29)
Exomes 𝑓: 0.054 ( 3104 hom. )

Consequence

STRC
NM_153700.2 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0120

Publications

6 publications found
Variant links:
Genes affected
STRC (HGNC:16035): (stereocilin) This gene encodes a protein that is associated with the hair bundle of the sensory hair cells in the inner ear. The hair bundle is composed of stiff microvilli called stereocilia and is involved with mechanoreception of sound waves. This gene is part of a tandem duplication on chromosome 15; the second copy is a pseudogene. Mutations in this gene cause autosomal recessive non-syndromic deafness. [provided by RefSeq, Jul 2008]
CKMT1B (HGNC:1995): (creatine kinase, mitochondrial 1B) Mitochondrial creatine (MtCK) kinase is responsible for the transfer of high energy phosphate from mitochondria to the cytosolic carrier, creatine. It belongs to the creatine kinase isoenzyme family. It exists as two isoenzymes, sarcomeric MtCK and ubiquitous MtCK, encoded by separate genes. Mitochondrial creatine kinase occurs in two different oligomeric forms: dimers and octamers, in contrast to the exclusively dimeric cytosolic creatine kinase isoenzymes. Many malignant cancers with poor prognosis have shown overexpression of ubiquitous mitochondrial creatine kinase; this may be related to high energy turnover and failure to eliminate cancer cells via apoptosis. Ubiquitous mitochondrial creatine kinase has 80% homology with the coding exons of sarcomeric mitochondrial creatine kinase. Two genes located near each other on chromosome 15 have been identified which encode identical mitochondrial creatine kinase proteins. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018331409).
BP6
Variant 15-43601535-C-T is Benign according to our data. Variant chr15-43601535-C-T is described in ClinVar as Benign. ClinVar VariationId is 165304.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0568 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STRCNM_153700.2 linkc.4562G>A p.Arg1521Gln missense_variant Exon 24 of 29 ENST00000450892.7 NP_714544.1 Q7RTU9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STRCENST00000450892.7 linkc.4562G>A p.Arg1521Gln missense_variant Exon 24 of 29 5 NM_153700.2 ENSP00000401513.2 Q7RTU9

Frequencies

GnomAD3 genomes
AF:
0.0412
AC:
6249
AN:
151832
Hom.:
225
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00990
Gnomad AMI
AF:
0.0751
Gnomad AMR
AF:
0.0301
Gnomad ASJ
AF:
0.0791
Gnomad EAS
AF:
0.000772
Gnomad SAS
AF:
0.0291
Gnomad FIN
AF:
0.0758
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.0583
Gnomad OTH
AF:
0.0461
GnomAD2 exomes
AF:
0.0459
AC:
11537
AN:
251130
AF XY:
0.0471
show subpopulations
Gnomad AFR exome
AF:
0.00964
Gnomad AMR exome
AF:
0.0257
Gnomad ASJ exome
AF:
0.0767
Gnomad EAS exome
AF:
0.000598
Gnomad FIN exome
AF:
0.0704
Gnomad NFE exome
AF:
0.0601
Gnomad OTH exome
AF:
0.0502
GnomAD4 exome
AF:
0.0544
AC:
79437
AN:
1461564
Hom.:
3104
Cov.:
32
AF XY:
0.0540
AC XY:
39231
AN XY:
727100
show subpopulations
African (AFR)
AF:
0.00887
AC:
297
AN:
33478
American (AMR)
AF:
0.0272
AC:
1214
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0750
AC:
1959
AN:
26128
East Asian (EAS)
AF:
0.000605
AC:
24
AN:
39692
South Asian (SAS)
AF:
0.0371
AC:
3200
AN:
86244
European-Finnish (FIN)
AF:
0.0653
AC:
3485
AN:
53386
Middle Eastern (MID)
AF:
0.0940
AC:
542
AN:
5764
European-Non Finnish (NFE)
AF:
0.0590
AC:
65639
AN:
1111780
Other (OTH)
AF:
0.0510
AC:
3077
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
4095
8189
12284
16378
20473
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2370
4740
7110
9480
11850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0411
AC:
6248
AN:
151950
Hom.:
225
Cov.:
29
AF XY:
0.0419
AC XY:
3108
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.00987
AC:
409
AN:
41438
American (AMR)
AF:
0.0301
AC:
459
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0791
AC:
274
AN:
3464
East Asian (EAS)
AF:
0.000774
AC:
4
AN:
5168
South Asian (SAS)
AF:
0.0291
AC:
140
AN:
4814
European-Finnish (FIN)
AF:
0.0758
AC:
800
AN:
10552
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0584
AC:
3965
AN:
67936
Other (OTH)
AF:
0.0456
AC:
96
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
298
596
894
1192
1490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0473
Hom.:
205
Bravo
AF:
0.0365
TwinsUK
AF:
0.0647
AC:
240
ALSPAC
AF:
0.0576
AC:
222
ESP6500AA
AF:
0.0109
AC:
48
ESP6500EA
AF:
0.0606
AC:
521
ExAC
AF:
0.0465
AC:
5645
Asia WGS
AF:
0.0140
AC:
48
AN:
3478
EpiCase
AF:
0.0593
EpiControl
AF:
0.0577

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg1521Gln in Exon 24 of STRC: This variant is not expected to have clinical sig nificance because it has been identified in 6.0% (422/7018) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs74643365). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.044
T;.
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.71
FATHMM_MKL
Benign
0.0066
N
LIST_S2
Benign
0.67
T;T
MetaRNN
Benign
0.0018
T;T
MetaSVM
Benign
-1.0
T
PhyloP100
0.012
PrimateAI
Benign
0.43
T
PROVEAN
Benign
0.16
N;N
REVEL
Benign
0.063
Sift
Benign
0.31
T;T
Sift4G
Benign
0.57
T;T
Polyphen
0.0010
B;P
Vest4
0.20
ClinPred
0.0063
T
GERP RS
1.7
Varity_R
0.061
gMVP
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74643365; hg19: chr15-43893733; COSMIC: COSV107359476; COSMIC: COSV107359476; API